Phase ii study of bendamustine in relapsed and refractory hodgkin lymphoma
Antineoplastic Agents, Alkylating
Nitrogen Mustard Compounds
This study confirms the efficacy of bendamustine in heavily pretreated patients with HL. These results support current and future studies evaluating bendamustine combinations in relapsed and refractory HL.